Skip to main content
Premium Trial:

Request an Annual Quote

Bigtime for Big Genetics

Over at Genetic Future, Daniel MacArthur writes about the promises and challenges of big genetics. This year, he writes, we'll see major data releases from several large-scale projects, including the 1,000 Genomes Project and the Cancer Genome Atlas, and disease genetics consortia such as the Wellcome Trust Case Control Consortium, GIANT, and dozens of other groups. He argues that big genetics studies will continue to lead to smaller ones, and the key point in the continuing success of big genetics is free access to the data. "Anything that interferes with open data access is a threat to the research community as a whole -- so we need to be wary both of an excessive focus on commercialisation within academia, and of well-meaning but excessive attempts to control the flow of data."

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.